441 related articles for article (PubMed ID: 28027332)
1. Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.
Lees AJ; Ferreira J; Rascol O; Poewe W; Rocha JF; McCrory M; Soares-da-Silva P;
JAMA Neurol; 2017 Feb; 74(2):197-206. PubMed ID: 28027332
[TBL] [Abstract][Full Text] [Related]
2. Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial.
Ferreira JJ; Lees A; Rocha JF; Poewe W; Rascol O; Soares-da-Silva P;
Lancet Neurol; 2016 Feb; 15(2):154-165. PubMed ID: 26725544
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.
Schapira AH; Fox SH; Hauser RA; Jankovic J; Jost WH; Kenney C; Kulisevsky J; Pahwa R; Poewe W; Anand R
JAMA Neurol; 2017 Feb; 74(2):216-224. PubMed ID: 27942720
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study.
Reichmann H; Lees A; Rocha JF; Magalhães D; Soares-da-Silva P;
Transl Neurodegener; 2020 Mar; 9(1):9. PubMed ID: 32345378
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.
Ferreira JJ; Lees A; Rocha JF; Poewe W; Rascol O; Soares-da-Silva P
Eur J Neurol; 2019 Jul; 26(7):953-960. PubMed ID: 30681754
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.
Ferreira JJ; Lees AJ; Poewe W; Rascol O; Rocha JF; Keller B; Soares-da-Silva P
Neurology; 2018 May; 90(21):e1849-e1857. PubMed ID: 29695590
[TBL] [Abstract][Full Text] [Related]
7. Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
Hauser RA; Stocchi F; Rascol O; Huyck SB; Capece R; Ho TW; Sklar P; Lines C; Michelson D; Hewitt D
JAMA Neurol; 2015 Dec; 72(12):1491-500. PubMed ID: 26523919
[TBL] [Abstract][Full Text] [Related]
8. Safety Profile of Opicapone in the Management of Parkinson's Disease.
Lees A; Ferreira JJ; Rocha JF; Rascol O; Poewe W; Gama H; Soares-da-Silva P
J Parkinsons Dis; 2019; 9(4):733-740. PubMed ID: 31498127
[TBL] [Abstract][Full Text] [Related]
9. Opicapone: A Review in Parkinson's Disease.
Scott LJ
Drugs; 2016 Sep; 76(13):1293-1300. PubMed ID: 27498199
[TBL] [Abstract][Full Text] [Related]
10. Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.
Fabbri M; Ferreira JJ; Lees A; Stocchi F; Poewe W; Tolosa E; Rascol O
Mov Disord; 2018 Oct; 33(10):1528-1539. PubMed ID: 30264443
[TBL] [Abstract][Full Text] [Related]
11. Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease.
Ferreira JJ; Rocha JF; Falcão A; Santos A; Pinto R; Nunes T; Soares-da-Silva P
Eur J Neurol; 2015 May; 22(5):815-25, e56. PubMed ID: 25649051
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and efficacy of opicapone in Japanese Parkinson's patients with motor fluctuations.
Takeda A; Takahashi R; Tsuboi Y; Nomoto M; Maeda T; Nishimura A; Yoshida K; Hattori N
J Neural Transm (Vienna); 2021 Mar; 128(3):337-344. PubMed ID: 33630140
[TBL] [Abstract][Full Text] [Related]
13. Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.
Chaudhuri KR; Odin P; Ferreira JJ; Antonini A; Rascol O; Kurtis MM; Storch A; Bannister K; Soares-da-Silva P; Costa R; Magalhães D; Rocha JF
BMC Neurol; 2022 Mar; 22(1):88. PubMed ID: 35279112
[TBL] [Abstract][Full Text] [Related]
14. Opicapone to Treat Early Wearing-off in Parkinson's Disease Patients: The Korean ADOPTION Trial.
Lee JY; Ma HI; Ferreira JJ; Rocha JF; Sung YH; Song IU; Ahn TB; Kwon DY; Cheon SM; Kim JM; Lee CS; Lee PH; Park JH; Lee JH; Park MY; Kim SJ; Baik JS; Choi SM; Shin HW; Lee HW; Kang SY; Jeon B
Mov Disord Clin Pract; 2024 Jun; 11(6):655-665. PubMed ID: 38594812
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
Parkinson Study Group
Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Opicapone for Motor Fluctuations as an Adjuvant to Levodopa Therapy in Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Kwak N; Park J; Kang HY; Lee MJ; Suh JK; Lee H
J Parkinsons Dis; 2022; 12(3):773-783. PubMed ID: 35180134
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Espay AJ; Stocchi F; Pahwa R; Albanese A; Ellenbogen A; Ferreira JJ; Giladi N; Gurevich T; Hassin-Baer S; Hernandez-Vara J; Isaacson SH; Kieburtz K; LeWitt PA; Lopez-Manzanares L; Olanow CW; Poewe W; Sarva H; Yardeni T; Adar L; Salin L; Lopes N; Sasson N; Case R; Rascol O;
Lancet Neurol; 2024 May; 23(5):465-476. PubMed ID: 38499015
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.
Borgohain R; Szasz J; Stanzione P; Meshram C; Bhatt M; Chirilineau D; Stocchi F; Lucini V; Giuliani R; Forrest E; Rice P; Anand R;
Mov Disord; 2014 Feb; 29(2):229-37. PubMed ID: 24323641
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients with Motor Fluctuations.
Takeda A; Takahashi R; Tsuboi Y; Nomoto M; Maeda T; Nishimura A; Yoshida K; Hattori N
Mov Disord; 2021 Feb; 36(2):415-423. PubMed ID: 33073879
[TBL] [Abstract][Full Text] [Related]
20. Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson's disease: a systematic review and meta-analysis.
Żegleń M; Śladowska K; Kawalec P; Brzostek T
J Comp Eff Res; 2022 Aug; 11(12):889-904. PubMed ID: 35758044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
